(ii)

the reporting lines for Investment Analysts and their remuneration arrangements where such matters give rise to any conflicts of interest which may reasonably be likely to impair the impartiality of the Investment Research;

(iii)

any shareholding by the Authorised Person or its Associate of 1% or more of the total issued share capital of the Issuer;

(iv)

if the Authorised Person or its Associate acts as corporate broker for the Issuer;

(v)

any material shareholding by the Issuer in the Authorised Person;